Email Updates

Search form

You are here

AIDS Vaccines

There is momentum and promise in the search for an AIDS vaccine.

An effective preventive AIDS vaccine would teach the body how to prevent HIV infection. Vaccines are the most powerful public health tools available—and an AIDS vaccine would play a powerful role in ensuring the end to the AIDS epidemic.

While effective vaccines remain years away, there are more reasons for hope than ever before. Researchers are expanding on the result of a 2009 trial that showed, for the first time, that a vaccine can reduce the risk of HIV infection. They’re also pursuing groundbreaking research with other novel vaccine strategies, including broadly neutralizing antibodies that target a wide range of HIV strains. At the same time, there is also exciting work in efforts to understand if and how to cure HIV in people who are already infected. The timeline for this work is long and uncertain. Here, too, advocacy is needed to sustain momentum.

Today’s momentum depends on sustained funding. Policy makers and funders around the world must have the courage to sustain vital AIDS vaccine research for years to come, and advocates must keep the pressure on them to maintain their commitments.

What We're Reading

With recent advances in ARV-based HIV prevention implementation, some may ask whether the world still needs an AIDS vaccine to end the epidemic. A new modeling analysis, published this month in the open-access journal PLoS ONE, answers this question with a resounding yes.

January 5, 2016
PLoS One

An accessible article, including strong graphics, about broadly neutralizing antibodies: how long it takes them to mature, and how scientists are trying to understand this process to make an effective vaccine.

December 16, 2015
Daily Mail
Subscribe to RSS - AIDS Vaccines